MatthewHoMDPhD

Hematology/Oncology

Physician

Dr. Ho is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2020 - 2023
University College of Dublin National Univ SOMClass of 2020

PubMed

Extramedullary Multiple Myeloma: Challenges and Opportunities.
Matthew Ho, Luca Paruzzo, Janna Minehart, Neel Nabar, Julia Han Noll
Current Oncology. 2025-03-20
Nontuberculous mycobacterial infections following teclistamab in multiple myeloma.
Matthew Ho, Luca Paruzzo, Janna Minehart, Teja Voruganti, Pooja Devi
Haematologica. 2025-02-06
9 citations
Chimeric antigen receptor T-cell therapy in hematologic malignancies: Successes, challenges, and opportunities.
Matthew Ho, Saurabh Zanwar, Jonas Paludo
European Journal of Haematology. 2024-02-01

Journal Articles

Targeting Protein Synthesis and Degradation in Multiple Myeloma
Ho M, Bianchi G, American Journal of Hematology and Oncology
Exploiting Autophagy in Multiple Myeloma
Ho M, Patel A, Hanley C, Murphy A, McSweeney T, Zhang L, McCann A, O’Gorman P, Bianchi G, Journal of Cancer Metastasis and Treatment
ROBO1 Promotes Homing, Dissemination, and Survival of Multiple Myeloma within the Bone Marrow Microenvironment
Bianchi G, Czarnecki PG, Ho M, Roccaro AM, Sacco A, Kawano Y, Gulla A, Samur AA, Chen T, Wen K, Tai YT, Moscvin M, Wu X, Camci-Unal G, Claudio, M, Bolli N, Sewastianik..., Blood Cancer Discovery
Proteomics inspired precision medicine for treating and understanding multiple myeloma
Ho M, Bianchi G, & Anderson KC, Expert Review of Precision Medicine and Drug Development 2020, 2/20/2020
Join now to see all